JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barria, A.
Right arrow Articles by Soderling, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barria, A.
Right arrow Articles by Soderling, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 52, Issue of December 26, 1997 pp. 32727-32730

COMMUNICATION:
Identification of the Ca2+/Calmodulin-dependent Protein Kinase II Regulatory Phosphorylation Site in the alpha -Amino-3-hydroxyl-5-methyl4-isoxazole-propionate-type Glutamate Receptor*

(Received for publication, September 11, 1997, and in revised form, October 25, 1997)

Andres Barria Dagger , Victor Derkach and Thomas Soderling §

From the Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

Ca2+/CaM-dependent protein kinase II (CaM-KII) can phosphorylate and potentiate responses of alpha -amino3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptors in a number of systems, and recent studies implicate this mechanism in long term potentiation, a cellular model of learning and memory. In this study we have identified this CaM-KII regulatory site using deletion and site-specific mutants of glutamate receptor 1 (GluR1). Only mutations affecting Ser831 altered the 32P peptide maps of GluR1 from HEK-293 cells co-expressing an activated CaM-KII. Likewise, when CaM-KII was infused into cells expressing GluR1, the Ser831 to Ala mutant failed to show potentiation of the GluR1 current. The Ser831 site is specific to GluR1, and CaM-KII did not phosphorylate or potentiate current in cells expressing GluR2, emphasizing the importance of the GluR1 subunit in this regulatory mechanism. Because Ser831 has previously been identified as a protein kinase C phosphorylation site (Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J., and Huganir, R. L. (1996) Neuron 16, 1179-1188), this raises the possibility of synergistic interactions between CaM-KII and protein kinase C in regulating synaptic plasticity.


INTRODUCTION

Brief trains of high frequency stimulation to monosynaptic excitatory pathways in the hippocampus and several other brain regions cause an abrupt and sustained increase in the efficiency of synaptic transmission. This phenomenon, known as long term potentiation (LTP),1 is a cellular model for learning and memory (1-3). LTP induction requires activation of ionotropic N-methyl-D-aspartate-type glutamate receptors, Ca2+ influx into the postsynaptic dendritic spine, and activation of postsynaptic protein kinases (1-3). Ionotropic alpha -amino-3-hydroxyl-5-methyl-4-isoxazole-propionate glutamate receptors (AMPA-Rs) in the postsynaptic densities of excitatory synapses are primarily responsible for basal rapid excitatory transmission and for the enhancement of synaptic current in LTP (4, 5). AMPA-Rs are heterocomplexes composed of subunits GluR1-GluR4 (6), and these channels can be modulated by phosphorylation. Infusion of activated Ca2+/calmodulin-dependent protein kinase II (CaM-KII) potentiates AMPA-R responsiveness in Xenopus oocytes and HEK-293 cells expressing GluR1 (7) or of native AMPA-Rs in hippocampal cultured neurons (8), dorsal root ganglion cells (9), and hippocampal slice CA1 neurons (10, 11). In the latter system, expression or infusion of CaM-KII not only increases AMPA-R responsiveness, but it also increases synaptic current and occludes subsequent induction of LTP, suggesting common mechanisms for potentiation. A crucial role for CaM-KII in the induction of LTP is strongly indicated (12), and we recently demonstrated phosphorylation of AMPA-Rs by CaM-KII after LTP induction in hippocampal slices (13). Although phosphorylation of AMPA-Rs by CaM-KII appears to be a key event in LTP (12), this regulatory phosphorylation site has not been positively identified. Previous studies have implicated Ser627 in GluR1 (7), Ser696 in GluR2 (14), and Ser684 and/or Ser666 in GluR6 (15, 16) as regulatory phosphorylation sites by various kinases, but the revised membrane topology model places these sites extracellular (17, 18). PKA and PKC can also phosphorylate AMPA-Rs in cortical neurons and GluR1 expressed in 293 cells (19), and recently the PKA (Ser845) and PKC (Ser831) phosphorylation sites in GluR1 were identified in the intracellular COOH terminus (20). In this paper we have re-examined the CaM-KII regulatory phosphorylation site using site-specific mutagenesis and electrophysiology of recombinant AMPA-type glutamate receptors.


EXPERIMENTAL PROCEDURES

Phosphorylation of AMPA-Rs and Two-dimensional Peptide Mapping

HEK-293 cells were transfected with AMPA-Rs (wild type or mutants) and CaM-KII H282R in a ratio 2:1. At confluency, cells were incubated in phosphate-free Dulbecco's modified Eagle's medium for 4 h and then labeled with [32P]orthophosphate during 90 min. After labeling, cells were rinsed with cold phosphate-buffered saline and harvested in homogenization buffer containing 500 mM NaCl, 30 mM Na4P2O7, 50 mM NaF, 50 mM Tris-HCl (pH 7.5), 200 mM EDTA, 200 mM EGTA, 100 mM Na3VO4, 0.1 mM leupeptin, 1 mM phenylmethylsulfonyl fluoride, 20 µg/µl soybean trypsin inhibitor, 1 µM microcystine-LR, 0.5% Triton X-100, and 0.1% deoxycholate. Samples were sonicated and centrifuged at 10.000 rpm for 15 min. The receptor was immunoprecipitated from the supernatant and analyzed by SDS-PAGE and autoradiography. Two dimensional peptide mapping was performed as in Ref. 13 except that the electrophoresis step was increased from 70 to 90 min. This results in the resolution of two distinct peptides, 1 and 2. All shown peptide maps were reproduced at least three times.

Kinase Assays

HEK-293 cells were transfected (CaM-KII H282R or mock) and homogenized as above, and PKC was assayed in the supernatant at 30 °C using 50 mM HEPES (pH 7.5), 10 mM magnesium acetate, 1 mM dithiothreitol, 0.1 mM [32P]ATP, 0.1 mM myristoylated alanine-rich C kinase substrate protein, with or without 0.3 mM CaCl2, 20 mol % phosphatidylserine, and 5 mol % 1,2-dioleoyl glycerol. CaM-KII was assayed (21) using 40 µM Syntide-2 as a substrate, and 1 mM CaCl2 and 2 µM CaM for total activity or 2 mM EGTA for Ca2+-independent activity.

Expression and Phosphorylation of GST-GluR1816-889

The COOH terminus of GluR1 (residues 816-889) was cloned into pGEX-4T-2 (Pharmacia Biotech Inc.), and the fusion protein was expressed and purified according to company protocols. The fusion construct was phosphorylated in medium containing 50 mM Tris-HCl (pH 7.5), 10 mM magnesium acetate, 1 mM CaCl2, 2 µM CaM, 0.1 mM [32P]ATP, and 1 nM CaM-KII. At different times the reaction was stopped with SDS-sample buffer and resolved by SDS-PAGE for analysis by autoradiography. Quantification of the radioactivity was done using Phosphor Screen from Molecular Dynamics.

AMPA Receptor Currents (13)

Wild type or mutant GluR1 were expressed in HEK-293 cells using Lipofectine (Life Technologies, Inc.) and seeded at low density. Whole cells recording were made 16-20 h after transfection as has been reported previously. When added to intracellular solution, activated CaM-KII truncated at residue 316 and autothiophosphorylated (11) was at 0.4 µM. Glutamate was delivered to single cells by rapid application (7).


RESULTS AND DISCUSSION

We have reported that mutagenesis of Ser627 eliminates the effect of CaM-KII on AMPA currents in Xenopus oocytes expressing GluR1 (7). Because the revised membrane topological model places this site extracellular (17, 18), we examined whether if Ser627 is phosphorylated by CaM-KII. Wild type GluR1 or mutant GluR1 S627A were expressed in HEK-293 cells, metabolically 32P-labeled, and then immunoprecipitated with GluR1 antibody and separated by SDS-PAGE (13). Low basal phosphorylation was observed, but co-expression of GluR1 with a mutant (H282R) of CaM-KII, which has 20% constitutive activity, significantly increased the 32P labeling of either GluR1 wild type or the S627A mutant (Fig. 1A, upper left panel). Transfection with CaM-KII gave a 2-3-fold increase in total CaM-KII activity and a large increase in constitutive activity (Fig. 1A, right panel) that catalyzed the phosphorylation of co-expressed GluR1. Because CaM-KII might phosphorylate GluR1 at several sites, two-dimensional phosphopeptide mapping was performed. The mapping conditions were modified (see "Experimental Procedures") and resulted in resolution of two major phosphopeptides 1 and 2 (Fig. 1B) rather than a single, broad spot as previously reported (13). In the absence of transfected CaM-KII, basal phosphorylation of wild type GluR1 was predominantly in peptide 1 (Fig. 1B, left panel), whereas co-expressed CaM-KII produced a large increase in peptide 2 phosphorylation (Fig. 1B, middle panel). Because the maps of wild type GluR1 and mutant GluR1 S627A appeared identical (Fig. 1B, middle and right panels), this demonstrated that the CaM-KII phosphorylation site was not Ser627. Wild type GluR1 expressed in HEK-293 cells shows a small run-down of current over 30 min, and infusion of activated CaM-KII through the patch pipette potentiates wild type GluR1 current by 50-75% (13). Mutant GluR1 S627A did not exhibit run-down but exhibited some spontaneous potentiation, and CaM-KII failed to further potentiate the current (Fig. 1C, right panel), similar to what we observed in Xenopus oocytes (7). The mutation of Ser627 may alter the normal conformation of the receptor, preventing its modulation by phosphorylation. Interestingly, another mutant, consensus CaM-KII site Ser593 to Ala in intracellular loop 2, showed similar behavior; it had a 32P peptide map identical to wild type GluR1, indicating that this site was not phosphorylated by CaM-KII, but infusion of CaM-KII did not potentiate its current (data not shown).


Fig. 1. Ser627 is not the CaM-KII regulatory phosphorylation site on GluR1. A, phosphorylation of wild type (WT) or mutant S627A GluR1 expressed in HEK-293 cells with or without coexpression of the CaM-KII mutant H282R, which has 20% constitutive activity (21). Two days after transfection, cells were 32P-labeled and GluR1 was immunoprecipitated as described previously (13). Equal amounts of the receptor were separated by SDS-PAGE and analyzed by autoradiography (left top panel) and for GluR1 immunoreactivity (left bottom panel). The right panel compares constitutive (-Ca2+) and total (+Ca2+) CaM-KII activities from mock transfected or CaM-KII (H282R mutant) transfected cells. B, the 32P-GluR1 was excised from the gel and subjected to complete tryptic digestion followed by two-dimensional peptide mapping; the two main phosphopeptides are circled and labeled. C, effect of CaM-KII on whole cell currents (-80 mV, insets), in response to a 100-ms application of 10 mM glutamate (13), recorded from HEK-293 cells expressing wild type (left panel, n = 9-10 cells) or mutant S627A (right panel, n = 4-5 cells) GluR1. Peak currents were normalized to zero time for cells infused with activated (CaM-KII) or with heat-inactivated CaM-KII (HI CaM-KII) (13).

[View Larger Version of this Image (54K GIF file)]


These results directed our strategy to identify mutations that lacked both the CaM-KII 32P labeling and potentiation. A previous study identified phosphorylation sites for PKC (Ser831) and PKA (Ser845) in the intracellular COOH terminus of GluR1 (20), so we examined whether a fusion construct of GST and GluR1 COOH-terminal residues 816-889 was phosphorylated by CaM-KII. GST itself was not phosphorylated by CaM-KII (not shown), but the fusion construct was slowly phosphorylated (Fig. 2A, left panel), and its peptide map contained predominantly phosphopeptide 2 (Fig. 2B). Therefore, we concentrated on mutations of consensus CaM-KII sites (Arg-Xaa-Xaa-(Ser/Thr)) within the COOH terminus of GluR1. Triple mutant GluR1 S814A,S816A,S818A and single mutant GluR1 S863A were phosphorylated in HEK-293 cells by co-expressed CaM-KII to a similar extent as wild type GluR1, and their two-dimensional maps were identical to that of wild type GluR1 (data not shown). Deletion of amino acids 829-844 (GluR1 Delta 829-844) eliminated CaM-KII phosphorylation, whereas deletion of amino acids 845-859 (GluR1 Delta 845-859) did not prevent receptor phosphorylation in 293 cells (Fig. 3A). These experiments indicated that the CaM-KII phosphorylation site may be located within residues 829-844, so we tested the effect of mutating Ser831 to Ala in the GluR1 COOH terminus of the GST fusion construct. This mutation blocked phosphorylation of the GST fusion protein (Fig. 2A, right panel), implicating Ser831 as a likely candidate for the CaM-KII phosphorylation site (Fig. 2A). The S831A mutant of full-length GluR1 was not phosphorylated by CaM-KII (Fig. 3B, upper panel) when co-expressed in 293 cells; it was devoid of major phosphopeptide 2 in its two-dimensional map (Fig. 3B, lower panel), and its current was not potentiated by CaM-KII (Fig. 3C, left panel). In contrast to the S831A mutant, the adjacent PKA site mutant (GluR1 S845A) was still phosphorylated by CaM-KII; its two-dimensional map was comparable with the wild type (Fig. 3B, right panel); and its current was potentiated (Fig. 3C, right panel).


Fig. 2. CaM-KII phosphorylates GluR1 on the intracellular COOH-terminal domain. A, phosphorylation of GST fusion protein containing GluR1 COOH-terminal residues 816-889, wild type (WT, left top panel) or with S831A mutation (right top panel). Purified GST/GluR1816-889 fusion constructs (1 µM) were phosphorylated in vitro by 1 nM CaM-KII for 0, 5, 15, 30, or 60 min at 30 °C, separated in SDS-PAGE, and analyzed by autoradiography. The lower panel represents data from two experiments (solid line is wild type; dotted line is S831A). B, two-dimensional tryptic peptide map of the GST/GluR1816-889 (wild type) phosphorylated by CaM-KII for 1 h. Phosphopeptide 2 is circled.

[View Larger Version of this Image (39K GIF file)]



Fig. 3. Mutation of Ser831, but not Ser845, blocks CaM-KII phosphorylation of GluR1 and potentiation of its current. A, autoradiography of immunoprecipitated GluR1 mutants lacking residues 829-844 or 845-859 32P-labeled by co-expressed CaM-KII in HEK-293 cells. Arrows indicate the position of the receptor. B, phosphorylation of GluR1 single mutants S831A or S845A by co-expressed CaM-KII. The top panel is the autoradiograph of the SDS-PAGE; the 32P-GluR1 was cut from the gel and subjected to two-dimensional tryptic peptide mapping in the bottom panel. C, whole cell recordings of GluR1 mutants expressed in HEK-293 cells. Peak currents were normalized to zero time for cells expressing GluR1 mutants Ser831Ala (n = 4-5 cells) or S845A (n = 3-4 cells) after infusion of activated or heat-inactivated CaM-KII (13).

[View Larger Version of this Image (55K GIF file)]


These results (Fig. 3, B and C) demonstrate that Ser831 was the regulatory CaM-KII phosphorylation site. This site is unique to GluR1 because GluR2-6 subunits do not contain sites homologous to Ser831. Therefore, one would predict that co-expression of CaM-KII with GluR2 might not enhance its phosphorylation, and this was observed (Fig. 4A). Likewise, infusion of CaM-KII into cells expressing GluR2 did not potentiate its current (Fig. 4B). This specificity of CaM-KII for GluR1 would implicate a unique role for GluR1 in potentiating synaptic current through its phosphorylation. This may account for a major role of CaM-KII in mediating LTP in region CA1 of hippocampus because most native AMPA-Rs should contain GluR1 because only GluR1 and GluR2 are strongly expressed (22).


Fig. 4. GluR2 is not phosphorylated or potentiated by CaM-KII. A, HEK-293 cells were transfected with GluR2 with or without CaM-KII H282R and 32P-labeled, and the receptor was immunoprecipitated (13) using a commercial GluR2 antibody (Upstate Biotechnology). The arrow indicates the position of the receptor after SDS-PAGE. B, normalized peak currents from whole cell recordings of HEK-293 cells expressing GluR2 and infused with active (bullet , n = 5 cells) or heat inactivated (square , n = 4 cells) CaM-KII. C, activity of PKC in HEK-293 cells transfected without (MOCK) or with CaM-KII H282R.

[View Larger Version of this Image (21K GIF file)]


Consistent with the previous report (20), the S831A mutant failed to show enhanced phosphorylation upon stimulation of the 32P-labeled cells with phorbol ester (not shown). The two-dimensional phosphopeptide map of the wild type GluR1 phosphorylated upon stimulation of the cells with TPA was indistinguishable from the map of wild type GluR1 phosphorylated by co-expressed CaM-KII (not shown). One possible interpretation of these data would be that activation of PKC leads to an increase in the endogenous CaM-KII activity through an increase in free calmodulin as has been demonstrated in PC12 cells (23). The activated CaM-KII could then catalyze phosphorylation of the AMPA-R. However, in the present study TPA treatment (1 µM for 15 min) did not increase the activity of CaM-KII in 293 cells co-expressing CaM-KII and GluR1 (not shown), as assessed by immunoprecipitated 32P-CaM-KII (i.e. autophoshorylation), just as was previously observed in cultured hippocampal neurons treated with TPA (24). There is no established mechanism by which CaM-KII can activate PKC, and we did not see any increase in PKC activity comparing cells without (mock) and with transfected CaM-KII H282R (Fig. 4C).

Because CaM-KII and PKC phosphorylate the same regulatory site in GluR1, this raises the possibility that both kinases might regulate synaptic plasticity through this mechanism. Both kinases can phosphorylate GluR1 in isolated rat brain postsynaptic densities and cultured hippocampal neurons (24). In the postsynaptic density CaM-KII is several orders of magnitude stronger as a catalyst, perhaps because of its high concentration in this synaptic organelle compared with PKC. Both CaM-KII (13, 25, 26) and PKC (27-31) are activated for a prolonged period upon LTP induction, and it has been reported that only a combination of inhibitors of both kinases can turn off established LTP (32). Although the role of CaM-KII in LTP through phosphorylation of AMPA-Rs has extensive experimental support (12, 13), an additional role for PKC should also be considered. It is also interesting that Ser831 is not a "consensus" phosphorylation site for either CaM-KII or PKC, presumably explaining its slow rate of phosphorylation in the GST fusion construct (Fig. 2A) and the slow potentiation of GluR1 current in 293 cells (Fig. 1B), which correlate with the slow phosphorylation of AMPA-Rs by CaM-KII after induction of LTP (13). The fact that Ser831 is not a good substrate for CaM-KII may be an important physiological checkpoint in that it would prevent AMPA-R phosphorylation and synaptic potentiation by weak synaptic input. Only intensive synaptic activity would be able to elevate CaM-KII activity for a sufficient time to slowly phosphorylate the AMPA-R and thereby enhance postsynaptic current. These results implicate Ser831 as a "memory locus" on the AMPA-R and make its mutation a prime candidate for testing on learning and memory in animal models.


FOOTNOTES

*   This work was supported in part by Javits Neuroscience Investigator Award NS 27037 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Ph. D. student from the University of Chile.
§   To whom correspondence should be addressed: Vollum Inst. L-474, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd., Portland, OR 97201. Tel.: 503-494-6931; Fax: 503-494-4534; E-mail: soderlit{at}oshu.edu.
1   The abbreviations used are: LTP, long term potentiation; AMPA-R, alpha -amino-3-hydroxyl-5-methyl-4-isoxazole-propionate glutamate receptor; CaM-KII, Ca2+/calmodulin-dependent protein kinase II; GluR, glutamate receptor; PKA, protein kinase A; PKC, protein kinase C; PAGE, polyacrylamide gel electrophoresis; GST, glutathione S-transferase; TPA, 12-O-tetradecanoylphorbol-13-acetate.

REFERENCES

  1. Bliss, T. V. P., and Collingridge, G. L. (1993) Nature 361, 31-39 [CrossRef][Medline] [Order article via Infotrieve]
  2. Malinow, R. (1994) Science 266, 1195-1198 [Free Full Text]
  3. Larkman, A. U., and Jack, J. B. (1995) Curr. Opin. Neurobiol. 5, 324-334 [CrossRef][Medline] [Order article via Infotrieve]
  4. Kauer, J., Malenka, R., and Nicoll, R. (1988) Neuron 1, 911-917 [CrossRef][Medline] [Order article via Infotrieve]
  5. Kullmann, D., and Siegelbaum, S. (1995) Neuron 15, 997-1002 [CrossRef][Medline] [Order article via Infotrieve]
  6. Hollmann, M., and Heinemann, S. (1994) Annu. Rev. Neurosci. 17, 31-108 [CrossRef][Medline] [Order article via Infotrieve]
  7. Yakel, J., Prabhakar, V., Derkach, V., Brickey, D., and Soderling, T. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1376-1380 [Abstract/Free Full Text]
  8. McGlade-McCulloh, E., Yamamoto, H., Tan, S.-E., Brickey, D., and Soderling, T. (1993) Nature 362, 640-642 [CrossRef][Medline] [Order article via Infotrieve]
  9. Kolaj, M., Cerne, R., Cheng, G., Brickey, D. A., and Randic, M. (1994) J. Neurophysiol. 72, 2525-2531 [Abstract/Free Full Text]
  10. Pettit, D. L., Perlman, S., and Malinow, R. (1994) Science 266, 1881-1885 [Abstract/Free Full Text]
  11. Lledo, P.-M., Hjelmstad, G., Mukherji, S., Soderling, T., Malenka, R., and Nicoll, R. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 11175-11179 [Abstract/Free Full Text]
  12. Lisman, J., Malenka, R. C., Nicoll, R. A., and Malinow, R. (1997) Science 276, 2001-2002 [Free Full Text]
  13. Barria, A., Muller, D., Derkach, V., Griffith, L. C., and Soderling, T. R. (1997) Science 276, 2042-2045 [Abstract/Free Full Text]
  14. Nakazawa, K., Mikawa, S., Hashikawa, T., and Ito, M. (1995) Neuron 15, 697-709 [CrossRef][Medline] [Order article via Infotrieve]
  15. Raymond, L. A., Blackstone, C. D., and Huganir, R. L. (1993) Nature 361, 637-641 [CrossRef][Medline] [Order article via Infotrieve]
  16. Wang, L. Y., Taverna, F. A., Huang, X. P., MacDonald, J. F., and Hampson, D. R. (1993) Science 259, 1173-1175 [Abstract/Free Full Text]
  17. Hollmann, M., Maron, C., and Heinemann, S. (1994) Neuron 13, 1331-1343 [CrossRef][Medline] [Order article via Infotrieve]
  18. Hollmann, M. (1997) in The Ionotropic Glutamate Receptors (Monaghan, D. T., and Wenthold, R. J., eds), pp. 39-79, Humana, Totowa, NJ
  19. Blackstone, C., Murphy, T., Moss, S., Baraban, J., and Huganir, R. (1994) J. Neurosci. 14, 7585-7593 [Abstract]
  20. Roche, K. W., O'Brien, R. J., Mammen, A. L., Bernhardt, J., and Huganir, R. L. (1996) Neuron 16, 1179-1188 [CrossRef][Medline] [Order article via Infotrieve]
  21. Brickey, D. A., Bann, J. G., Fong, Y. L., Perrino, L., Brennan, R. G., and Soderling, T. R. (1994) J. Biol. Chem. 269, 29047-29054 [Abstract/Free Full Text]
  22. Petralia, R., and Wenthold, R. (1992) J. Comp. Neurol. 318, 329-354 [CrossRef][Medline] [Order article via Infotrieve]
  23. MacNicol, M., and Schulman, H. (1992) J. Biol. Chem. 267, 12197-12201 [Abstract/Free Full Text]
  24. Tan, S.-E., Wenthold, R. J., and Soderling, T. R. (1994) J. Neurosci. 14, 1123-1129 [Abstract]
  25. Fukunaga, K., Stoppini, L., Miyamoto, E., and Muller, D. (1993) J. Biol. Chem. 268, 7863-7867 [Abstract/Free Full Text]
  26. Fukunaga, K., Muller, D., and Miyamoto, E. (1995) J. Biol. Chem. 270, 6119-6124 [Abstract/Free Full Text]
  27. Frey, U., Huang, Y. Y., and Kandel, E. R. (1993) Science 260, 1661-1664 [Abstract/Free Full Text]
  28. Hu, G. Y., Hvalby, O., Walaas, S. I., Albert, K. A., Skjeflo, P., Andersen, P., and Greengard, P. (1987) Nature 328, 426-429 [CrossRef][Medline] [Order article via Infotrieve]
  29. Klann, E., Chen, S. J., and Sweatt, J. D. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8337-8341 [Abstract/Free Full Text]
  30. Sacktor, T. C., Osten, P., Valsamis, H., Jiang, X., Naik, M. U., and Sublette, E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8342-8346 [Abstract/Free Full Text]
  31. Roberson, E. D., and Sweatt, J. D. (1996) J. Biol. Chem. 271, 30436-30441 [Abstract/Free Full Text]
  32. Wang, J. H., and Kelly, P. T. (1995) Neuron 15, 443-452 [CrossRef][Medline] [Order article via Infotrieve]

Volume 272, Number 52, Issue of December 26, 1997 pp. 32727-32730
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. S. Guire, M. C. Oh, T. R. Soderling, and V. A. Derkach
Recruitment of Calcium-Permeable AMPA Receptors during Synaptic Potentiation Is Regulated by CaM-Kinase I
J. Neurosci., June 4, 2008; 28(23): 6000 - 6009.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Haines, L. M. Mao, L. Yang, A. Arora, E. E. Fibuch, and J. Q. Wang
Modulation of AMPA receptor GluR1 subunit phosphorylation in neurons by the intravenous anaesthetic propofol
Br. J. Anaesth., May 1, 2008; 100(5): 676 - 682.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Tavalin
AKAP79 Selectively Enhances Protein Kinase C Regulation of GluR1 at a Ca2+-Calmodulin-dependent Protein Kinase II/Protein Kinase C Site
J. Biol. Chem., April 25, 2008; 283(17): 11445 - 11452.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X. Sun, M. Milovanovic, Y. Zhao, and M. E. Wolf
Acute and Chronic Dopamine Receptor Stimulation Modulates AMPA Receptor Trafficking in Nucleus Accumbens Neurons Cocultured with Prefrontal Cortex Neurons
J. Neurosci., April 16, 2008; 28(16): 4216 - 4230.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Du, T. K. Creson, L.-J. Wu, M. Ren, N. A. Gray, C. Falke, Y. Wei, Y. Wang, R. Blumenthal, R. Machado-Vieira, et al.
The Role of Hippocampal GluR1 and GluR2 Receptors in Manic-Like Behavior
J. Neurosci., January 2, 2008; 28(1): 68 - 79.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
C. Villmann and C.-M. Becker
On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor
Neuroscientist, December 1, 2007; 13(6): 594 - 615.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
J. Y. Delgado, M. Coba, C. N. G. Anderson, K. R. Thompson, E. E. Gray, C. L. Heusner, K. C. Martin, S. G. N. Grant, and T. J. O'Dell
NMDA Receptor Activation Dephosphorylates AMPA Receptor Glutamate Receptor 1 Subunits at Threonine 840
J. Neurosci., November 28, 2007; 27(48): 13210 - 13221.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. C. Brown, S. S. Correia, C. N. Petrok, and J. A. Esteban
Functional Compartmentalization of Endosomal Trafficking for the Synaptic Delivery of AMPA Receptors during Long-Term Potentiation
J. Neurosci., November 28, 2007; 27(48): 13311 - 13315.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Shukla, J. Kim, J. Blundell, and C. M. Powell
Learning-induced Glutamate Receptor Phosphorylation Resembles That Induced by Long Term Potentiation
J. Biol. Chem., June 22, 2007; 282(25): 18100 - 18107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Y. Yuen, W. Liu, and Z. Yan
The Phosphorylation State of GluR1 Subunits Determines the Susceptibility of AMPA Receptors to Calpain Cleavage
J. Biol. Chem., June 1, 2007; 282(22): 16434 - 16440.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Akaneya and T. Tsumoto
Bidirectional Trafficking of Prostaglandin E2 Receptors Involved in Long-Term Potentiation in Visual Cortex
J. Neurosci., October 4, 2006; 26(40): 10209 - 10221.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. R. Hardingham, N. J. Bannister, J. C. A. Read, K. D. Fox, G. E. Hardingham, and J. J. B. Jack
Extracellular calcium regulates postsynaptic efficacy through group 1 metabotropic glutamate receptors.
J. Neurosci., June 7, 2006; 26(23): 6337 - 6345.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Gebhardt and S. G. Cull-Candy
Influence of agonist concentration on AMPA and kainate channels in CA1 pyramidal cells in rat hippocampal slices
J. Physiol., June 1, 2006; 573(2): 371 - 394.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Tsui and R. C. Malenka
Substrate Localization Creates Specificity in Calcium/Calmodulin-dependent Protein Kinase II Signaling at Synapses
J. Biol. Chem., May 12, 2006; 281(19): 13794 - 13804.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. Y. Cheng, L. J. Martin, E. M. Elliott, J. H. Kim, H. T. J. Mount, F. A. Taverna, J. C. Roder, J. F. MacDonald, A. Bhambri, N. Collinson, et al.
Alpha5GABAA receptors mediate the amnestic but not sedative-hypnotic effects of the general anesthetic etomidate.
J. Neurosci., April 5, 2006; 26(14): 3713 - 3720.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. M. Vanhoose, J. M. Clements, and D. G. Winder
Novel Blockade of Protein Kinase A-Mediated Phosphorylation of AMPA Receptors
J. Neurosci., January 25, 2006; 26(4): 1138 - 1145.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. Oh, V. A. Derkach, E. S. Guire, and T. R. Soderling
Extrasynaptic Membrane Trafficking Regulated by GluR1 Serine 845 Phosphorylation Primes AMPA Receptors for Long-term Potentiation
J. Biol. Chem., January 13, 2006; 281(2): 752 - 758.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C.-S. Chan, E. J. Weeber, L. Zong, E. Fuchs, J. D. Sweatt, and R. L. Davis
{beta}1-Integrins Are Required for Hippocampal AMPA Receptor-Dependent Synaptic Transmission, Synaptic Plasticity, and Working Memory
J. Neurosci., January 4, 2006; 26(1): 223 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. O. Solomonia, A. Kotorashvili, T. Kiguradze, B. J. McCabe, and G. Horn
Ca2+/calmodulin protein kinase II and memory: learning-related changes in a localized region of the domestic chick brain
J. Physiol., December 1, 2005; 569(2): 643 - 653.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. A. Taha and M. P. Stryker
Ocular dominance plasticity is stably maintained in the absence of {alpha} calcium calmodulin kinase II ({alpha}CaMKII) autophosphorylation
PNAS, November 8, 2005; 102(45): 16438 - 16442.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. M. Ramsey, M. M. Adams, O. J. Ariwodola, W. E. Sonntag, and J. L. Weiner
Functional Characterization of Des-IGF-1 Action at Excitatory Synapses in the CA1 Region of Rat Hippocampus
J Neurophysiol, July 1, 2005; 94(1): 247 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Zou, L. Li, L. Pei, B. Vukusic, H. H. M. Van Tol, F. J. S. Lee, Q. Wan, and F. Liu
Protein-Protein Coupling/Uncoupling Enables Dopamine D2 Receptor Regulation of AMPA Receptor-Mediated Excitotoxicity
J. Neurosci., April 27, 2005; 25(17): 4385 - 4395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Tsui, M. Inagaki, and H. Schulman
Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Localization Acts in Concert with Substrate Targeting to Create Spatial Restriction for Phosphorylation
J. Biol. Chem., March 11, 2005; 280(10): 9210 - 9216.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. Zhao, J. B. Watson, and C.-W. Xie
Amyloid {beta} Prevents Activation of Calcium/Calmodulin-Dependent Protein Kinase II and AMPA Receptor Phosphorylation During Hippocampal Long-Term Potentiation
J Neurophysiol, November 1, 2004; 92(5): 2853 - 2858.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Hayashi and R. L. Huganir
Tyrosine Phosphorylation and Regulation of the AMPA Receptor by Src Family Tyrosine Kinases
J. Neurosci., July 7, 2004; 24(27): 6152 - 6160.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H.-W. Yang, X.-D. Hu, H.-M. Zhang, W.-J. Xin, M.-T. Li, T. Zhang, L.-J. Zhou, and X.-G. Liu
Roles of CaMKII, PKA, and PKC in the Induction and Maintenance of LTP of C-Fiber-Evoked Field Potentials in Rat Spinal Dorsal Horn
J Neurophysiol, March 1, 2004; 91(3): 1122 - 1133.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
V. A. Derkach
Silence Analysis of AMPA Receptor Mutated at the CaM-Kinase II Phosphorylation Site
Biophys. J., March 1, 2003; 84(3): 1701 - 1708.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
A. Contractor and S. F. Heinemann
Glutamate Receptor Trafficking in Synaptic Plasticity
Sci. Signal., October 29, 2002; 2002(156): re14 - re14.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Cai, Z. Gu, P. Zhong, Y. Ren, and Z. Yan
Serotonin 5-HT1A Receptors Regulate AMPA Receptor Channels through Inhibiting Ca2+/Calmodulin-dependent Kinase II in Prefrontal Cortical Pyramidal Neurons
J. Biol. Chem., September 20, 2002; 277(39): 36553 - 36562.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
W. Kakegawa, N. Yamada, M. Iino, K. Kameyama, T. Umeda, K. Tsuzuki, and S. Ozawa
Postsynaptic Expression of a New Calcium Pathway in Hippocampal CA3 Neurons and Its Influence on Mossy Fiber Long-Term Potentiation
J. Neurosci., June 1, 2002; 22(11): 4312 - 4320.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. C. Poncer, J. A. Esteban, and R. Malinow
Multiple Mechanisms for the Potentiation of AMPA Receptor-Mediated Transmission by alpha -Ca2+/Calmodulin-Dependent Protein Kinase II
J. Neurosci., June 1, 2002; 22(11): 4406 - 4411.
[Abstract] [Full Text] [PDF]